Identifying Candidates for Immunotherapy with Cemiplimab to Treat Advanced Cutaneous Squamous Cell Carcinoma: An Expert Opinion

A multi-disciplinary advisory group of Italian cutaneous squamous cell carcinoma (CSCC) experts was convened to develop criteria to assist in identifying appropriate candidates for cemiplimab therapy in advanced CSCC, based on the literature and clinical experience.